Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 32.00 | |
10 mg | In stock | $ 46.00 | |
25 mg | In stock | $ 84.00 | |
50 mg | In stock | $ 126.00 | |
100 mg | In stock | $ 173.00 | |
200 mg | In stock | $ 282.00 | |
500 mg | In stock | $ 413.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy. |
Synonyms | Zebinix, Aptiom, BIA 2-093, Exalief, Stedesa |
Molecular Weight | 296.32 |
Formula | C17H16N2O3 |
CAS No. | 236395-14-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 9 mg/mL (30.4 mM)
DMSO: 55 mg/mL (185.6 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eslicarbazepine Acetate 236395-14-5 Membrane transporter/Ion channel Neuroscience Sodium Channel Beta-Secretase Na channels Beta-secretase Eslicarbazepine Zebinix BACE inhibit Na+ channels Aptiom BIA 2-093 β-Secretase Inhibitor Exalief Stedesa inhibitor